6.41
+0.19(+3.05%)
Currency In USD
Address
One Kendall Square
Cambridge, MA 02139-1562
United States of America
Phone
781-315-4600
Website
Sector
Healthcare
Industry
Biotechnology
Employees
112
First IPO Date
October 03, 2019
| Name | Title | Pay | Year Born |
| Dr. Ram Aiyar MBA, Ph.D. | Chief Executive Officer, President, Interim Chief Financial Officer, Principal Financial Officer & Director | 939,075 | 1978 |
| Mr. Jeffrey M. Cerio J.D., Pharm.D. | Senior Vice President, General Counsel & Corporate Secretary | 615,025 | N/A |
| Dr. Olukemi A. Olugemo M.D. | Advisor | 649,724 | 1976 |
| Dr. Venkat Krishnamurthy Ph.D. | Senior Vice President & Head of Platform | 0 | N/A |
| Mr. Oliver Dolan | Senior Vice President of Finance & Principal Accounting Officer | 0 | 1983 |
| Ms. Stephanie Engels | Chief People Officer | 0 | N/A |
| Dr. Joshua Rosenthal Ph.D. | Co-Founder & Advisor | 0 | N/A |
| Dr. Loic Vincent Ph.D. | Chief Scientific Officer | 0 | N/A |
| Dr. Andrew Fraley Ph.D. | Co-Founder & Advisor | 0 | N/A |
| Mr. Todd Chappell M.B.A. | Chief Operating Officer | 0 | 1973 |
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.